Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1925 of 6351
-
New hope for chemo patients: drug may shield nerves from painful side effect
Symptom relief CompletedOxaliplatin is effective in adjuvant and first-line colorectal cancer chemotherapy. Oxaliplatin-induced severe chronic neurotoxicity is the main dose-limiting adverse event. No standard treatment for oxaliplatin-induced chronic toxicity has been defined. Neurotropin has been iden…
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a targeted drug revive blood cell production in a Pre-Leukemic condition?
Disease control OngoingThis is an open-label, multicenter study exploring the efficacy of ivosidenib in patients with clonal cytopenia of undetermined significance (CCUS) with mutations in IDH1. The purpose is to establish proof of principle that ivosidenib is well-tolerated and potentially efficacious…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
PRP shots may ease nerve pain from chemo
Symptom relief CompletedThis study aims to show the efficacy and safety of ultra-sound guided peri-neural platelet rich injection in treatment of chemotherapy induced peripheral neuropathy.
Phase 2 • Sponsor: South Egypt Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Robotic arm brace could restore movement in chronic stroke patients
Symptom relief Recruiting nowThis study will evaluate the effects of combining motor learning-based therapy with use of the MyoPro , a wearable exoskeletal myoelectrically controlled orthotic device. MyoPro uses electromyographic (EMG) signals from the weak muscles to assist movement of the user's affected a…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Keyhole surgery vs. open chest: which is better for osteosarcoma lung spread?
Disease control Recruiting nowThis phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of su…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a clotting booster cut blood loss in ICU patients?
Disease control Recruiting nowAssessment of high-normal dosage of Wilate ® compared to placebo administered in combination with platelets to assess reduction of amount of blood loss, need of transfusion products and outcome (length of stay, mortality) in patients with bleeding in comparison.
Phase 4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
A shot that might dull post-surgery pain and cut opioid use in teens
Symptom relief CompletedThe main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the st…
Phase 4 • Sponsor: Connecticut Children's Medical Center • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New HIV vaccine and antibody cocktail aims to free patients from daily meds
Disease control CompletedA multicenter, randomized, parallel-group, placebo-controlled, double-blind, Phase 1/2a clinical study to investigate the safety, tolerability, immunogenicity and exploratory efficacy of a vaccine regimen consisting of an Ad26.Mos4.HIV prime and a boost with Modified Vaccinia Ank…
Phase 1/2 • Sponsor: Boris Juelg, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart artery showdown: CT vs ultrasound for stent placement
Disease control OngoingComputed tomography (CT) has become an established tool in the diagnostic workup of patients with suspected coronary artery disease (CAD). The availability of coronary CT angiography (CCTA) before the invasive procedure allows stratifying case complexity and can be used to improv…
Sponsor: CoreAalst BV • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New MRI technique could catch osteoarthritis years earlier
Diagnosis Recruiting nowCurrently the diagnosis of OA is based on radiographs and clinical findings, which is limited to detecting late-stage disease. There is a pressing, unmet clinical need for robust assessment of early changes in cartilage health. Towards this goal, extensive efforts are ongoing to …
Sponsor: Xiaojuan Li • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Smart bike could help Parkinson's patients exercise from home
Symptom relief CompletedThis research will develop novel and accessible way to deliver effective and customized rehab to those suffering from common and devastating neurodegenerative condition called Parkinson's disease. The investigators will examine the efficacy of novel rehab technique that can be mo…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New study offers hope for parents struggling with grief after Child's cancer death
Symptom relief Recruiting nowThe purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Suppo…
Sponsor: University of Miami • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a cancer drug help heart transplant patients get a match?
Disease control By invitation onlyThe purpose of this study is to learn about how well the drug daratumumab/hyaluronidase-fihj (DARZALEX Faspro™) helps to lower high levels of HLA (Human Leukocyte Antigen) antibodies in a person waiting for a heart transplant.
Phase 2 • Sponsor: Barry A. Boilson • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis is an prospective, multicenter, single-arm clinical study.
Phase 4 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tests better ways to link former inmates to HIV and addiction treatment
Disease control CompletedThis is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Peer-Led events could help more black men start HIV prevention
Prevention Recruiting nowThe goal of the proposed research is to design a peer-based community intervention focused on addressing HIV stigma, and peer support to increase PrEP initiation in Prince George's County, MD. Participants will attend intervention events focused on stigma reduction and building c…
Sponsor: George Mason University • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Gut bacteria capsules take on superbugs in antibiotic patients
Disease control CompletedRandomized, placebo-controlled trial to evaluate the safety and efficacy of oral intestinal microbiota capsules for decolonizing multidrug-resistant organisms (MDROs) and Clostridioides difficile in patients requiring prolonged antibiotic therapy. The primary outcome was clearanc…
Phase 1/2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibody drug could reduce infusions for nerve disorder
Disease control CompletedThis is a phase 2, randomized, double-blinded, placebo-controlled, parallel-group, multicenter trial to evaluate the safety and efficacy of 2 dose regimens of ARGX-117 versus placebo, in participants with MMN previously stabilized with IVIg (intravenous immunoglobulin).
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Robotic arm could help people with paralysis regain independence at home
Symptom relief CompletedFor all individuals deprived of active and functional motor control of the upper limbs to perform grasping tasks, the restoration of a grasping function becomes a priority. The population concerned is mainly represented by so-called functional tetraplegic individuals. In this c…
Sponsor: Association APPROCHE • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to fight tough pancreatic cancer
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability and efficacy of JPI-547 in combination with modified FOLFIRINOX (mFOLFIRINOX) or Gemcitabine-nab-paclitaxel (GemAbraxne) in patients with locally advanced and metastatic pancreatic cancer
Phase 1/2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC